U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07433634) titled 'Time to BBVNA Relief' on Feb. 19.
Brief Summary: Basivertebral nerve ablation (BVNA) is a minimally invasive procedure approved for vertebrogenic low back pain. While early studies support its efficacy, real-world evidence is still evolving, particularly regarding the trajectory of pain relief and functional improvement over time, and predictors of clinical response. This study aims to evaluate clinical outcomes longitudinally following BVNA and identify baseline predictors of response.
Study Start Date: April 19, 2024
Study Type: OBSERVATIONAL
Condition:
Low Back Pain
Vertebrogenic Pain Syndrome
Basivertebral Nerve Ablation
In...